GlassScriptPhysician profile
Finny George
NPI 1033477377
$6,345.07
in general payments reported to CMS, 2019-2025
19 companies · $505 in 2025
The $505 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $125 · 2021: $31.59 · 2022: $1,947 · 2023: $1,495 · 2024: $1,943 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,508 · Grant: $1,381 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,508.48 |
| Grant | $1,380.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,491.36 | 2023-2024 | |
| Sientra, INC. | $1,221.60 | 2019-2022 | |
| Allergan, INC. | $714.28 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $572.39 | 2024-2025 | |
| Davol INC. | $519.37 | 2022-2025 | Phasix Mesh |
| Axogen | $499.40 | 2022-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Innovation Technologies INC | $379.48 | 2023 | Irrisept |
| Tela Bio, INC. | $200.00 | 2024 | Ovitex 2s |
| Integra Lifesciences Corporation | $171.30 | 2023-2024 | Durasorb Monofilament Mesh, Integra, Primatrix |
| Biotronik INC. | $158.08 | 2024 | Amvia Edge |
| Polynovo North America LLC | $149.02 | 2024 | Novosorb Btm |
| Nuvasive, INC. | $89.08 | 2020 | |
| Merz North America, INC. | $42.04 | 2024 | |
| Ethicon US, LLC | $29.87 | 2024 | Dermabond, Stratafix |
| Solventum Corporation | $29.86 | 2024 | Prevena |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $28.87 | 2024 | |
| Mentor Worldwide LLC | $18.92 | 2021 | |
| Merck Sharp & Dohme LLC | $17.48 | 2023 | Bridion |
| Misonix INC | $12.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Finny George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.